Delivery Order SPE2DB22D2206-SPE2DB25FJK08
Award Date 8/13/25
Potential Completion Date 9/4/25
Potential Value $53K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $51,879.46 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Revlimid 5 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award utilizes no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $53,251.31 to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (100-count units) on July 24, 2025, with completion expected by August 14, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Revlimid 25 mg capsule medication. The $20,562.98 contract has an ultimate completion date of April 24, 2024 and was awarded on April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.8K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (21-count packages) under a firm fixed-price contract with a ceiling value of $32,771.71. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 4, 2025, with fulfillment performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a ceiling value of $49,926.80 and a performance period ending on May 23, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products. The contract has a ceiling value of $18,722.57 and is for the delivery of Revlimid 25 mg capsules. The order has a firm fixed-price pricing type and the ultimate completion date is September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that the DLA Troop Support Medical has with AmerisourceBergen, valued at...